Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Artículo en Inglés | MEDLINE | ID: mdl-37743522

RESUMEN

BACKGROUND: To examine workplace factors associated with willingness to undergo human immunodeficiency virus (HIV) testing during workplace health checkups. METHODS: This cross-sectional study used an Internet-based self-administered questionnaire to obtain data from a pool of 24,287 Japanese workers. Binary and multiple logistic regression analyses evaluated the association between workplace factors and HIV testing. Data were adjusted for sex, age, marital status, education, and history of HIV testing. RESULTS: We gathered information from 4,143 (17.1%) respondents, of whom 1,129 (27.3%) were willing to be tested for HIV as part of a workplace health checkup. The participants were 20-59 years old. Approximately half of the participants were male (49.9%), half were married (48.9%), and half had completed higher education (47.6%). Workplace hepatitis testing was offered to 15.6% of the respondents, and most participants underwent health checkups without their colleagues (52.1%) at a medical facility (60.2%). Willingness to undergo HIV testing was positively correlated with having an increased risk of occupational blood exposure (vs. not at risk, adjusted odds ratio [OR]: 1.74, 95% confidence interval [CI]: 1.41-2.15) or working in medical and welfare roles (vs. manufacturing, OR: 1.40, 95% CI: 1.07-1.84). The presence of occupational health staff at the workplace (vs. their absence, adjusted OR: 1.35, 95% CI: 1.16-1.59) and hepatitis testing (vs. not testing, adjusted OR: 2.02, 95% CI: 1.66-2.44) increased willingness to undergo HIV testing. CONCLUSIONS: A pilot HIV-testing program involving individuals at an increased risk of occupational blood exposure and undergoing hepatitis tests in workplaces providing occupational health staff support is recommended.

3.
J Pediatr Hematol Oncol ; 45(4): e547-e550, 2023 05 01.
Artículo en Inglés | MEDLINE | ID: mdl-36706271

RESUMEN

The prognosis of children with KMT2A -rearranged ( KMT2A -r) acute lymphoblastic leukemia (ALL) remains dismal. This report describes the successful retransplantation of a patient with infant ALL who relapsed both bone marrow and central nervous system. The patient received HLA-matched cord blood transplantation (CBT) and relapsed 18 months later. After achieving the second remission, the patient received a killer cell immunoglobulin-like receptor ligand-mismatched CBT with a reduced-intensity conditioning regimen and has been in remission for 52 months. Thus, killer cell immunoglobulin-like receptor ligand-mismatched CBT with reduced-intensity conditioning might be a treatment option for patients with KMT2A- r ALL who relapsed after transplantation, even with extramedullary relapse.


Asunto(s)
Trasplante de Células Madre Hematopoyéticas , Leucemia-Linfoma Linfoblástico de Células Precursoras , Humanos , Leucemia-Linfoma Linfoblástico de Células Precursoras/cirugía , Receptores KIR , Femenino , Lactante , Resultado del Tratamiento
4.
J Occup Environ Med ; 64(3): e109-e113, 2022 03 01.
Artículo en Inglés | MEDLINE | ID: mdl-34889799

RESUMEN

OBJECTIVE: This study investigated the association between attending work while experiencing fever or cold symptoms and workers' socioeconomic background and company characteristics during the COVID-19 pandemic. METHODS: A cross-sectional online survey was performed. Of a total of 33,302 participants, 3676 workers who experienced fever or cold symptoms after April 2020 were included. The odds ratios (ORs) of attending work while sick associated with workers' socioeconomic background and company characteristics were evaluated using a multilevel logistic model. RESULTS: The OR of attending work while sick associated with a lack of policy prohibiting workers from working when ill was 2.75 (95% CI: 2.28 to 3.20, P < 0.001). CONCLUSION: This study suggests that clear company policies on work and illness can be effective for preventing employees from attending work while sick.


Asunto(s)
COVID-19 , COVID-19/epidemiología , Estudios Transversales , Humanos , Japón/epidemiología , Pandemias , SARS-CoV-2 , Clase Social
5.
Int J Hematol ; 113(2): 297-301, 2021 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-32979171

RESUMEN

Hemophagocytic lymphohistiocytosis (HLH) is a severe complication after allogeneic hematopoietic cell transplantation (HCT) and can cause graft failure or multi-organ failure. Here, we report two children with refractory HCT-associated HLH treated with ruxolitinib. In the first patient, ruxolitinib resolved fever, cytopenia and hyperferritinemia. In another patient, although severe hepatic failure, which developed and worsened before the administration of ruxolitinib, was irreversible, rapid improvement in fever, leukopenia and hyperferritinemia was observed. Of note, multiplex cytokine profiling showed amelioration of cytokine storm in both patients. Ruxolitinib may be an encouraging option for HCT-associated HLH.


Asunto(s)
Trasplante de Células Madre Hematopoyéticas/efectos adversos , Linfohistiocitosis Hemofagocítica/tratamiento farmacológico , Linfohistiocitosis Hemofagocítica/etiología , Pirazoles/uso terapéutico , Protocolos de Quimioterapia Combinada Antineoplásica/efectos adversos , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Preescolar , Manejo de la Enfermedad , Susceptibilidad a Enfermedades , Femenino , Trasplante de Células Madre Hematopoyéticas/métodos , Humanos , Lactante , Linfohistiocitosis Hemofagocítica/diagnóstico , Masculino , Nitrilos , Leucemia-Linfoma Linfoblástico de Células Precursoras B/complicaciones , Leucemia-Linfoma Linfoblástico de Células Precursoras B/diagnóstico , Leucemia-Linfoma Linfoblástico de Células Precursoras B/tratamiento farmacológico , Pirazoles/administración & dosificación , Pirazoles/efectos adversos , Pirimidinas , Trasplante Homólogo , Resultado del Tratamiento
6.
J Infect Chemother ; 25(5): 376-378, 2019 May.
Artículo en Inglés | MEDLINE | ID: mdl-30595347

RESUMEN

We report a pediatric case aged 10 years with Granulicatella adiacens-associated chronic mandibular osteomyelitis. The causative pathogen was uncertain because polymicrobial species were detected from the bacterial culture in bone marrow fluid. In contrast, G. adiacens was predominantly identified in the clone library analysis of the bacterial 16S rRNA gene sequence. Vancomycin to which G. adiacens was reported to be susceptible was not administrated sufficiently to this patient because of its adverse event, whereas linezolid and ciprofloxacin was alternatively effective for the treatment of chronic mandibular osteomyelitis.


Asunto(s)
Antibacterianos/uso terapéutico , Carnobacteriaceae/patogenicidad , Mandíbula/microbiología , Osteomielitis/microbiología , Carnobacteriaceae/genética , Carnobacteriaceae/aislamiento & purificación , Niño , Enfermedad Crónica/terapia , Legrado , Quimioterapia Combinada , Femenino , Humanos , Oxigenoterapia Hiperbárica , Mandíbula/diagnóstico por imagen , Osteomielitis/diagnóstico , Osteomielitis/patología , Osteomielitis/terapia , ARN Ribosómico 16S/aislamiento & purificación , Tomografía Computarizada por Rayos X , Resultado del Tratamiento
7.
Nagoya J Med Sci ; 80(4): 611-614, 2018 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-30587876

RESUMEN

Acute parvovirus B19 (B19) infection is often accompanied by autoantibody formation, including antinuclear antibodies and rheumatoid factor, and the symptoms of the infection are similar to those of several autoimmune diseases. Uveitis is a representative manifestation of autoimmune diseases and is rarely caused by B19. Autoantibody formation was confirmed in 2 previously reported cases with B19-associated uveitis. However, whether B19-associated uveitis is caused by the direct invasion of the virus or the induction of autoimmunity remains unclear. We herein report a pediatric case with B19-associated uveitis without autoantibody formation. We speculated that B19 might have directly invaded the eye in this patient because of the development of uveitis without antibody formation and the negative results for anti-B19-specific antibodies in the serum at the onset of the disease. Although the mechanism of invasion is unknown, B19 may have a high affinity for tissue in the eye.


Asunto(s)
Parvovirus B19 Humano/patogenicidad , Uveítis/virología , Formación de Anticuerpos/inmunología , Formación de Anticuerpos/fisiología , Autoanticuerpos/inmunología , Autoanticuerpos/fisiología , Autoinmunidad/inmunología , Autoinmunidad/fisiología , Niño , Humanos , Masculino
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA